He has over 20 years of first-chair trial experience in high-stakes intellectual property and technology disputes. John’s experience includes numerous trial representations in cases brought under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act as well as trade secret, licensing and contract disputes. Clients praise John for his “unique understanding of the interplay between IP, regulatory, and business issues in the pharmaceutical sector” and regularly turn to him for advice regarding patents, exclusivities and litigation risk concerning commercial and late-stage clinical assets.

John’s engagements have included trial representation before various federal courts and the Patent Trial and Appeal Board, appellate representation before the Federal Circuit and other courts of appeal. His experience includes work on numerous patent and trade secret cases involving a variety of technologies including pharmaceuticals, biotechnology, medical devices, telecommunications and internet content delivery systems. John also is frequently asked to conduct diligence, render opinions and perform freedom to operate analyses.

John actively engages in pro bono work, including appearing as lead counsel in federal litigation against the U.S. Government, which led to the release of Francisco Rodriguez-Guardado, a longtime Massachusetts Institute of Technology custodian and father of three U.S. citizen children, who was suddenly incarcerated and threatened with deportation in 2017-2018.